581 related articles for article (PubMed ID: 28649145)
1. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Handley AP; Williams M
J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
Azizi M; Khani S; Kamali M; Elyasi F
Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of nonhormonal drugs on menopausal hot flashes.
Li L; Xu L; Wu J; Dong L; Zhao S; Zheng Q
Eur J Clin Pharmacol; 2016 Sep; 72(9):1051-8. PubMed ID: 27450233
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
7. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
Kelsberg G; Maragh L; Safranek S
J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
[TBL] [Abstract][Full Text] [Related]
8. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
[TBL] [Abstract][Full Text] [Related]
9. SSRIs vs. SNRIs for Vasomotor Symptoms of Menopause.
Newhouser LM; Maneval M; Rayalam K; Sabeeh G; Varela L
Am Fam Physician; 2022 Apr; 105(4):430-431. PubMed ID: 35426647
[No Abstract] [Full Text] [Related]
10. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
Menown SJ; Tello JA
Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
13. SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials.
Shams T; Firwana B; Habib F; Alshahrani A; Alnouh B; Murad MH; Ferwana M
J Gen Intern Med; 2014 Jan; 29(1):204-13. PubMed ID: 23888328
[TBL] [Abstract][Full Text] [Related]
14. Managing vasomotor symptoms in women after cancer.
Pinkerton JV; Santen RJ
Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
Stearns V
Treat Endocrinol; 2006; 5(2):83-7. PubMed ID: 16542048
[TBL] [Abstract][Full Text] [Related]
16. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
17. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer.
Li T; Yang J; Lv Y; Yin F; Xu L; Liu H; Zheng Q; Li L
Breast Cancer Res Treat; 2019 Feb; 173(3):511-520. PubMed ID: 30390215
[TBL] [Abstract][Full Text] [Related]
19. The effect of serotonin reuptake inhibitors on the vaginal epithelium in postmenopausal women.
Shea AK; Meschino D; Wolfman W
Climacteric; 2019 Oct; 22(5):507-510. PubMed ID: 31060386
[No Abstract] [Full Text] [Related]
20. Efficacy of desvenlafaxine succinate for menopausal hot flashes.
Tella SH; Gallagher JC
Expert Opin Pharmacother; 2014 Nov; 15(16):2407-18. PubMed ID: 25252697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]